Italy· 048960013
HEPCLUDEX*30 flaconcini SC polv 2 mg
A bulevirtide product containing bulevirtide, registered in Italy by GILEAD SCIENCES IRELAND UC, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Bulevirtide is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AX28 (bulevirtide), each read from that country’s own register.
- This record: Italy
- 10 of them publish a price we can compare per daily dose
Bulevirtide · ATC J05AX28
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bulevirtide costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bulevirtide · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$219.16
The record
At a glance
- Active substance
- Bulevirtide
- Manufacturer
- GILEAD SCIENCES IRELAND UC
- Country
- Italy (IT)
- ATC code
- J05AX28
- ATC class
- Bulevirtide
- Defined daily dose
- 2 mg, P
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic048960013HEPCLUDEX*30 flaconcini SC polv 2 mgEUR 17201.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bulevirtide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainHEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLEGilead Sciences Ireland Unlimited Company
- FranceHEPCLUDEX 2 mg, poudre pour solution injectableGILEAD SCIENCES IRELAND UC (IRLANDE)
- United KingdomHepcludex 2mg powder for solution for injection vialsGilead Sciences Ltd
- IrelandHEPCLUDEX 2 mg powder for solution for injectionGilead Sciences Ireland UC
- IcelandHepcludexGilead Sciences Ireland UC*
- NetherlandsHepcludex 2 mg poeder voor oplossing voor injectieGilead Sciences Ireland UC
- NorwayHepcludexGilead Sciences Ireland UC
- PolandHepcludexGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Hepcludex
- Liechtenstein · Hepcludex
- Norway · Hepcludex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afd6fa27-ae6c-4c6a-87b8-ab0f6ed5f64b GET /v1/drugs/afd6fa27-ae6c-4c6a-87b8-ab0f6ed5f64b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 17201.33,
"source": "aifa",
"currency": "EUR",
"strength": "BULEVIRTIDE 2MG 30 UNITA' USO PARENTERALE",
"substance": "Bulevirtide",
"equivalence_group": "MLZ",
"transparency_flag": null
}See everything about bulevirtide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.